(Q43734392)

26 November 2017

title

Molecular field analysis of clozapine analogs in the development of a pharmacophore model of antipsychotic drug action (English)

1 reference

26 November 2017

Tehan BG

1

1 reference

26 November 2017

Lloyd EJ

series ordinal

2

1 reference

26 November 2017

Wong MG

series ordinal

3

1 reference

26 November 2017

language of work or name

1 reference

1 January 2001

1 reference

Journal of Molecular Graphics & Modelling

26 November 2017

published in

1 reference

26 November 2017

volume

19

1 reference

26 November 2017

issue

5

1 reference

26 November 2017

page(s)

417-26, 468

1 reference

Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2800%2900101-7

7 January 2021

Pharmacological actions of the atypical antipsychotic drug clozapine: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2800%2900101-7

7 January 2021

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2800%2900101-7

7 January 2021

Binding of 5H-dibenzo[b,e][1,4]diazepine and chiral 5H-dibenzo[a,d]cycloheptene analogues of clozapine to dopamine and serotonin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2800%2900101-7

7 January 2021

Binding of 5H-dibenzo[a,d]cycloheptene and dibenz[b,f]oxepin analogues of clozapine to dopamine and serotonin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2800%2900101-7

7 January 2021

Octoclothepin enantiomers. A reinvestigation of their biochemical and pharmacological activity in relation to a new receptor-interaction model for dopamine D-2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2800%2900101-7

7 January 2021

Neuroleptic receptors: Stereoselectivity for neuroleptic enantiomers

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2800%2900101-7

7 January 2021

Validation of the general purpose Tripos 5.2 force field

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2800%2900101-7

7 January 2021

Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2800%2900101-7

7 January 2021

Conformational analysis and structural comparisons of (1R,3S)-(+)- and (1S,3R)-(-)-tefludazine, (S)-(+)- and (R)-(-)-octoclothepin, and (+)-dexclamol in relation to dopamine receptor antagonism and amine-uptake inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2800%2900101-7

7 January 2021

HINT: a new method of empirical hydrophobic field calculation for CoMFA.

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2800%2900101-7

7 January 2021

Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2800%2900101-7

7 January 2021

Isolation and Structures of Dicyanide Derivatives, Epurpurins A to C, from Emericella purpurea.

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2800%2900101-7

7 January 2021

A common structural model for central nervous system drugs and their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2800%2900101-7

7 January 2021

CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2800%2900101-7

7 January 2021

10.1016/S1093-3263(00)00101-7

Identifiers

DOI

1 reference

26 November 2017

1 reference